125 related articles for article (PubMed ID: 20677552)
1. [Effect of liposomal transfection of UCH-L1 siRNA on proliferation and apoptosis of lung cancer cell line H157].
Qu X; Wang Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):292-6. PubMed ID: 20677552
[TBL] [Abstract][Full Text] [Related]
2. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.
Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ
J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis.
Kim HJ; Kim YM; Lim S; Nam YK; Jeong J; Kim HJ; Lee KJ
Oncogene; 2009 Jan; 28(1):117-27. PubMed ID: 18820707
[TBL] [Abstract][Full Text] [Related]
6. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.
Jin Y; Zhang W; Xu J; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Int J Clin Exp Pathol; 2015; 8(10):12500-8. PubMed ID: 26722437
[TBL] [Abstract][Full Text] [Related]
7. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
[TBL] [Abstract][Full Text] [Related]
8. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
Miyoshi Y; Nakayama S; Torikoshi Y; Tanaka S; Ishihara H; Taguchi T; Tamaki Y; Noguchi S
Cancer Sci; 2006 Jun; 97(6):523-9. PubMed ID: 16734731
[TBL] [Abstract][Full Text] [Related]
9. [Proliferation inhibition and apoptosis promotion induced by deletion of TMPO in A549].
Dong XY; Li WJ; Zhai B
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):742-747. PubMed ID: 31648495
[No Abstract] [Full Text] [Related]
10. Developmental regulation of ubiquitin C-terminal hydrolase isozyme expression during spermatogenesis in mice.
Kwon J; Wang YL; Setsuie R; Sekiguchi S; Sakurai M; Sato Y; Lee WW; Ishii Y; Kyuwa S; Noda M; Wada K; Yoshikawa Y
Biol Reprod; 2004 Aug; 71(2):515-21. PubMed ID: 15084487
[TBL] [Abstract][Full Text] [Related]
11. UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.
Luo Y; He J; Yang C; Orange M; Ren X; Blair N; Tan T; Yang JM; Zhu H
J Cell Biochem; 2018 Jan; 119(1):691-700. PubMed ID: 28636190
[TBL] [Abstract][Full Text] [Related]
12. The serine protease HtrA2 cleaves UCH-L1 and inhibits its hydrolase activity: implication in the UCH-L1-mediated cell death.
Park DW; Nam MK; Rhim H
Biochem Biophys Res Commun; 2011 Nov; 415(1):24-9. PubMed ID: 22001920
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity.
Kabuta T; Mitsui T; Takahashi M; Fujiwara Y; Kabuta C; Konya C; Tsuchiya Y; Hatanaka Y; Uchida K; Hohjoh H; Wada K
J Biol Chem; 2013 May; 288(18):12615-26. PubMed ID: 23543736
[TBL] [Abstract][Full Text] [Related]
14. N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage.
Kim HJ; Kim HJ; Jeong JE; Baek JY; Jeong J; Kim S; Kim YM; Kim Y; Nam JH; Huh SH; Seo J; Jin BK; Lee KJ
PLoS One; 2014; 9(6):e99654. PubMed ID: 24959670
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.
Bheda A; Shackelford J; Pagano JS
PLoS One; 2009 Aug; 4(8):e6764. PubMed ID: 19707515
[TBL] [Abstract][Full Text] [Related]
16. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line.
Liu Y; Lashuel HA; Choi S; Xing X; Case A; Ni J; Yeh LA; Cuny GD; Stein RL; Lansbury PT
Chem Biol; 2003 Sep; 10(9):837-46. PubMed ID: 14522054
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP
Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effects of the survivin siRNA transfection on human lung adenocarcinoma cells SPCA1 and SH77].
Liu Q; Dong C; Li L; Sun J; Li C; Li L
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):18-22. PubMed ID: 21219826
[TBL] [Abstract][Full Text] [Related]
19. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells].
Zhang X; Xu WH; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097
[TBL] [Abstract][Full Text] [Related]
20. UCH-L3 promotes non-small cell lung cancer proliferation via accelerating cell cycle and inhibiting cell apoptosis.
Li G; Jin X; Zheng J; Jiang N; Shi W
Biotechnol Appl Biochem; 2021 Feb; 68(1):165-172. PubMed ID: 32180254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
